Health-Care Deals up in Q1, but Expect Uncertainty from Virus

Health-care transactions increased in March, despite the pandemic’s effect on the economy, but Epstein Becker Green attorneys and health industry financial/investment analysts expect deal activity to slow over the second quarter. They say the virus is increasing productivity and innovation in some sectors while decreasing investment and growth in others. The Covid-19 pandemic has catalyzed some health-care industry subsectors to increase both productivity and innovation (e.g., life sciences and pharmaceuticals, health-care IT and software, medical devices and supplies), while investment and growth in other sectors (e.g., physician practices and services) is likely to slow down considerably given the practical challenges of curtailing in-person patient visits for non-emergent health-care services and elective surgeries. For example, deals in certain physician specialties (eye care, urology, dermatology, orthopedics, etc.) are likely to slow down for now, but accelerate as conditions stabilize. Moreover, both availability and pricing of debt financing may also put downward pressure on overall near-term deal activity.

Read the full article: Health-Care Deals up in Q1, but Expect Uncertainty from Virus //


Scroll to Top